drugset

drugset / Trial / NCT00155714

Efficacy of Type-5 Phosphodiesterase Inhibitors in Primary and Secondary Pulmonary Hypertension

NCT00155714 ↗

Withdrawn 20 enrolled National Taiwan University Hospital

Non-randomizedSingle-groupOpen-labelTreatment

Summary

The aim of this trial is to evaluate the efficacy of type-5 phosphodiesterase inhibitors (sildenafil) in primary and secondary pulmonary hypertension

Timeline

Start: 2002-11
Primary completion: —
Completion: 2005-05

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Sildenafil	Unknown	—	—

Indications